Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05268185 · ClinicalTrials.gov registry record · NA
The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19)
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 301
- Enrollment target
NCT05268185 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 301 participants.
The verdict
NCT05268185, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 301 participants
- Enrollment target
Study Summary
While both heterologous (mixing) and homologous (matching) vaccine regimens are now considered standard of care, post-vaccination complications and long-term effects of the different vaccination regimens have not been thoroughly studied. There is a pressing need to investigate the longitudinal effects of the mixing and matching vaccine-booster approaches. This study proposes to utilize the existing digital infrastructure of the COVID-19 Citizen Science (CCS) study on the Eureka Research Platform to perform a systematic and prospective randomized trial comparing mixing versus matching approaches. Eligible CCS participants will have the opportunity to be randomly assigned to a recommendation of receiving either the Pfizer or Moderna booster vaccine. Long-term effects will be monitored through the participants' completion of their regular weekly CCS follow-up surveys on symptoms and infection. This randomized trial aims to mitigate the effect of confounding variables and provide more conclusive evidence on each regiment to guide booster recommendations.
Interventions
- BEHAVIORAL Moderna Booster Vaccine
- BEHAVIORAL Pfizer Booster Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2022-01-18 |
| Est. Completion | 2023-01-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05268185
The ClinicalTrials.gov registry entry for NCT05268185 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 301 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Moderna Booster Vaccine is the first listed.
NCT05268185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05268185 about?
NCT05268185 is a clinical study titled "The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19)". While both heterologous (mixing) and homologous (matching) vaccine regimens are now considered standard of care, post-vaccination complications and long-term effects of the different vaccination regimens have not been thoroughly studied. There is a pressing need to investigate the longitudinal effec...
What is the current status of trial NCT05268185?
This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2022-01-18. Estimated completion is 2023-01-18.
What interventions are being tested in trial NCT05268185?
The interventions under investigation include: Moderna Booster Vaccine (BEHAVIORAL), Pfizer Booster Vaccine (BEHAVIORAL).
Who is sponsoring clinical trial NCT05268185?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.